Literature DB >> 23677657

Multifocal motor neuropathy.

Dustin G Nowacek1, James W Teener.   

Abstract

Multifocal motor neuropathy is an acquired disorder in which demyelination of motor axons, presumably due to autoimmune attack, results in progressive painless weakness without sensory loss. Motor axonal damage also occurs. It is a frequent mimic of motor neuron disease. Recognition of multifocal motor neuropathy is critical because it tends to be very responsive to treatment. Infusion of intravenous immunoglobulin is the initial treatment of choice, but other immunosuppressive treatments may also be effective. It appears that corticosteroids produce minimal benefit. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677657     DOI: 10.1055/s-0033-1334468

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  4 in total

Review 1.  Human immune globulin infusion in the management of multifocal motor neuropathy.

Authors:  Elizabeth Jovanovich; Chafic Karam
Journal:  Degener Neurol Neuromuscul Dis       Date:  2015-12-22

2.  A Wide Spectrum of Autoimmune Manifestations and Other Symptoms Suggesting Immune Dysregulation in Patients With Cartilage-Hair Hypoplasia.

Authors:  Svetlana Vakkilainen; Riikka Mäkitie; Paula Klemetti; Helena Valta; Mervi Taskinen; Eystein Sverre Husebye; Outi Mäkitie
Journal:  Front Immunol       Date:  2018-10-25       Impact factor: 7.561

Review 3.  Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment.

Authors:  Victoria H Lawson; W David Arnold
Journal:  Neuropsychiatr Dis Treat       Date:  2014-04-05       Impact factor: 2.570

4.  Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi-center, open-label, 52-week phase 3 trial.

Authors:  Satoshi Kuwabara; Sonoko Misawa; Masahiro Mori; Yuta Iwai; Kazuhide Ochi; Hidekazu Suzuki; Hiroyuki Nodera; Akira Tamaoka; Masahiro Iijima; Tatsushi Toda; Hiroo Yoshikawa; Takashi Kanda; Ko Sakamoto; Susumu Kusunoki; Gen Sobue; Ryuji Kaji
Journal:  J Peripher Nerv Syst       Date:  2018-04-24       Impact factor: 3.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.